PRT01 Latest Advances in Gene Expression Profiling (GEP) and GEP Guideline Updates for Cutaneous Melanoma
Fri, Mar 27, 10:30 AM - 11:15 AM
Exhibit Hall - Theater 1
Product Theater
DESCRIPTION
Review the development, validation, and clinical applications of the CP-GEP test in melanoma, featuring data from the largest prospective, multi-center blinded Melanoma GEP Study: MERLIN-001 published in JAMA Surgery Q4 2025 and recent Guideline Updates regarding the Merlin CP-GEP Test.
Presented by: SkylineDx USA, Inc.